|
Abstract:
|
Conducting pediatric clinical trials always involves stricter requirements from the regulatory agency than adult clinical trials, regarding the sample sizes and safety concerns. This presentation will focus on how to deal with some common issues for pediatric studies, including: 1) Adjusting randomization ratios to meet the minimum requirement of sample size from safety perspective; 2) Developing stopping rules related to specific Adverse Event or Event of Clinical Interest.
|
